Literature DB >> 9203584

The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation.

K H Kaestner1, D G Silberg, P G Traber, G Schütz.   

Abstract

The winged helix transcription factor Fkh6 is expressed in the mesoderm of the gastrointestinal tract directly adjacent to the endoderm-derived epithelium. Homozygous null mice for Fkh6 showed postnatal growth retardation secondary to severe structural abnormalities of the stomach, duodenum, and jejunum. Dysregulation of epithelial cell proliferation in these organs resulted in an approximately fourfold increase in the number of dividing intestinal epithelial cells and marked expansion of the proliferative zone. As a consequence, the tissue architecture of the stomach and small intestine was distorted, with abnormal crypt structure, formation of mucin filled cysts, and lengthening of villi. Changes in the cellular phenotype and composition of the gastric and intestinal epithelia also suggests that epithelial cell-lineage allocation or differentiation may be affected by loss of Fkh6. From the analysis of a number of potential signaling molecules, we found Bmp2 and Bmp4 expression reduced in the gastrointestinal tract of Fkh6 mutant mice, suggesting that Fkh6 directs a signaling cascade that mediates communication between the mesenchyme and endoderm of the gut to regulate cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203584     DOI: 10.1101/gad.11.12.1583

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  57 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  The intestinal stem cell niche: there grows the neighborhood.

Authors:  J C Mills; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  Epimorphin expression in intestinal myofibroblasts induces epithelial morphogenesis.

Authors:  Christine Fritsch; Elzbieta A Swietlicki; Olivier Lefebvre; Michele Kedinger; Hristo Iordanov; Marc S Levin; Deborah C Rubin
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 4.  Stem cell in gastrointestinal structure and neoplastic development.

Authors:  M Brittan; N A Wright
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

5.  Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesis.

Authors:  Pierre Lao-Sirieix; Rebecca Brais; Laurence Lovat; Nicholas Coleman; Rebecca C Fitzgerald
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

6.  Transcriptional repressor foxl1 regulates central nervous system development by suppressing shh expression in zebra fish.

Authors:  Chisako Nakada; Shinya Satoh; Yoko Tabata; Ken-ichi Arai; Sumiko Watanabe
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

7.  Hedgehog-responsive mesenchymal clusters direct patterning and emergence of intestinal villi.

Authors:  Katherine D Walton; Asa Kolterud; Michael J Czerwinski; Michael J Bell; Ajay Prakash; Juhi Kushwaha; Ann S Grosse; Santiago Schnell; Deborah L Gumucio
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 8.  Cellular and molecular partners involved in gut morphogenesis and differentiation.

Authors:  M Kedinger; O Lefebvre; I Duluc; J N Freund; P Simon-Assmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

9.  The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.

Authors:  Akito Tanoue; Yoshihisa Nasa; Takaaki Koshimizu; Hitomi Shinoura; Sayuri Oshikawa; Takayuki Kawai; Sachie Sunada; Satoshi Takeo; Gozoh Tsujimoto
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

10.  FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.

Authors:  Geng Zhang; Peijun He; Jochen Gaedcke; B Michael Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Nader Hanna; H Richard Alexander; S Perwez Hussain
Journal:  Cancer Res       Date:  2013-06-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.